Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Mergers, Acquisitions, and Partnerships news
(page 12)
13 April 2026
Toray Composite Materials America and Syensqo sign five-year carbon-fiber supply agreement for aerospace
Five-year carbon-fiber supply deal (effective Jan 2026) to secure supply for aircraft, space and defense, strengthening the global chain amid rising aerospace demand
13 April 2026
Petrobras greenlights SEAP I FID and advances contracting of two Sergipe‑Alagoas platforms
SEAP II FID had been approved earlier. SBM Offshore to build two BOT FPSOs with combined 240,000 bbl/d and 22 MMm3/d gas. Contract signing May 2026; production ~2030/2031; investment >R$60bn.
13 April 2026
Honeywell to supply liquefaction technology for Rio Grande LNG Trains 4–5
NextDecade will use CWHE and C3MR via Bechtel to boost reliability, cut OPEX and increase LNG output from 18 to 30 MTPA; all five trains expected online by mid-2031.
13 April 2026
Daiichi Sankyo and Merck: FDA Priority Review for Ifinatamab Deruxtecan in ES‑SCLC
BLA for ifinatamab deruxtecan accepted and granted FDA Priority Review for adult ES‑SCLC post‑platinum therapy; PDUFA Oct 10, 2026. Based on IDeate‑Lung01 Phase 2 (B7‑H3 DXd ADC).
13 April 2026
bp to acquire 60% interest in three Namibian offshore exploration blocks
Subject to Namibian approvals, the acquirer will operate PEL97, PEL99 and PEL100 in the Walvis Basin; Eco Atlantic and NAMCOR remain partners. Move builds on recent Azule Energy discoveries.
12 April 2026
GSK Mo‑Rez (B7‑H4 ADC) achieves 62% ORR in platinum‑resistant ovarian and 67% in endometrial cancer
BEHOLD-1 phase I: Mo-Rez (B7-H4 ADC) active across expression levels; manageable hematologic toxicity and nausea. 5.8 mg/kg recommended; five Phase III trials planned 2026
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
10 April 2026
Plenitude acquires Acea Energia
100% of an energy retail arm and 50% of a regional supplier acquired; adds 1.2M customers. Vulnerable customers excluded. Price ~€500M plus up to €100M earn‑out to 30/06/2027.
10 April 2026
WPU (Vitol) to build 80,000 t/yr chemical plastics recycling plant in Rotterdam
Uses batch pyrolysis to turn end-of-life plastics into pyrolysis oil as naphtha substitute; tech proven at a 20k t/yr Denmark plant; ties into VPR and Vopak storage.
10 April 2026
Paques Biomaterials supplies Caleyda PHA for circular bitumen
PHA biopolymer integrated into asphalt boosts bitumen performance and durability, enables circular supply, replaces fossil components, sequesters ~2 kg CO2/kg polymer, and aids 2030/2050 goals.
10 April 2026
Eni invests US$70M in Nouveau Monde Graphite
US$70M in a US$297M raise to fund Matawinie & Becancour; investor gains ~11.5% stake and board seat, secures exclusive graphite/anode supply for Brindisi gigafactory; pending AGM approval
10 April 2026
Petrobras to regain 100% of Tartaruga Verde and Espadarte Module III
Signed to acquire remaining 50% of Tartaruga Verde and Espadarte III for US$450M: $50M signing; $350M at close; two deferred $25M. Pending ANP approval. Fields producing ~55k b/d
9 April 2026
eFuels SEA launches Southeast Asia eFuel platform using Infinium tech
New Singapore-based platform will develop eFuel plants across Southeast Asia, converting captured CO2 and renewable power into drop-in eSAF and low-carbon fuels; aims for 3–5 projects.
9 April 2026
Gasunie and Fluxys sign JDA to link Dutch and Belgian hydrogen networks
Targeted by ~2030: cross-border bidirectional hydrogen connection using repurposed gas pipelines (Zandvliet node) to connect major ports/industrial clusters and enable integrated NW-European trade
9 April 2026
Worley Rosenberg awarded FEED for RjukanLH2, Nordic’s first liquid hydrogen plant
FEED (with EPC option) for 25 MW liquid hydrogen plant (10 t/day); modular design with pressurized alkaline electrolyzers and liquefaction; PPA-secured renewable power; production from 2028.
9 April 2026
Boehringer Ingelheim and BioNTech partner on ES‑SCLC immunotherapy trial
Phase Ib/II trial will test DLL3/CD3 T‑cell engager plus PD‑L1/VEGF‑A bispecific in extensive‑stage SCLC to boost durable antitumor immunity; dosing to start H2 2026
9 April 2026
BASF launches NeoHelix peptide and SkinNexus bio‑identical Collagen III
Two actives: a precision peptide reducing damaged collagen 41% and raising hyaluronic acid 65%; a recombinant bio‑identical Collagen III fragment that boosts Coll I/III/V and improves tone & wrinkles
9 April 2026
Galp acquires 351 MW Spanish onshore wind portfolio
17 operational wind assets (avg COD 2009) producing ~750 GWh/yr; equity value ~€320m, expected close 2Q26; raises renewables to 2 GW and wind share to ~25%
9 April 2026
Zenyaku Kogyo and Chugai end Rituxan co-promotion in Japan effective Sept 3, 2026
Rituxan co-promotion in Japan ends Sept 3, 2026. One partner will cease sales on sell-out; the other assumes sole sales and medical information from Sept 4. Transition to ensure stable supply.
8 April 2026
UPM Adhesive Materials and Mark Andy renew Americas partnership for seventh year
Leverages sustainable label materials and advanced printing tech to deliver label solutions optimized for performance, cost and sustainability across press types; shown in demo centers.
8 April 2026
Aptar Digital Health named Enable Injections' digital partner for enFuse
Companion digital solution for on-body injector to guide injections, support onboarding and training, record treatment and patient-reported outcomes, and provide secure adherence analytics.
8 April 2026
Elkem's Helge Aasen to step down as CEO, nominated as board chairman
Nomination committee’s proposals take effect after completion of the majority Silicones sale to Bluestar; the current CEO will stay on until a successor is in place. AGM 30 Apr 2026.
8 April 2026
Infinium’s Project Atlas Wins SABA Next‑Gen SAF Procurement
Selected eSAF project will supply SAF certificates via book-and-claim; airline to take delivery and manage logistics. ~100,000 MTPA, ~95% lifecycle CI reduction, RFNBO-compliant; production by 2029
8 April 2026
CELLforCURE seeks buyer for Les Ulis site
Seeking buyer to preserve cell & gene therapy manufacturing after funding slowdown, project cancellations and US relocation. Takeover sought in coming months; employee support prioritized.
8 April 2026
BASF at Techtextil 2026 — Practical textile solutions
At Techtextil 2026: showcases include mass‑balanced & biocircular polyamides, loopamid recycling, advanced binders and resins, and stretchable, PFAS‑free microporous TPU membranes.
8 April 2026
bp discovers gas offshore Egypt with fast-track potential
Denise W-1 in Temsah Concession found gas and condensate ~70 km offshore (95 m depth), <10 km from infrastructure; ~90 m gas-bearing sandstone; follows a 20-year concession renewal
8 April 2026
Brenntag signs exclusive global distribution deal with Insempra for Omega-7 biolipid
Exclusive global launch of CosVivet ActiLipid O7: precision-fermented Omega-7 biolipid for beauty - oil-soluble, hydrates sensitive skin, multifunctional and sustainable. Debuts at in-cosmetics Paris.
8 April 2026
Clariant showcases sustainable plastics innovations at Chinaplas 2026
PFAS-free PPAs for film extrusion and food contact; halogen/antimony‑free Exolit OP 1266 for 800V+ e‑mobility; rice‑bran wax food‑approved additives; titanium catalysts to replace antimony
7 April 2026
Southern Energy Renewables, Axens Sign MoU to Advance SAF in Louisiana
MoU: licensor to supply SAF and CO2-capture tech; project developer to lead site, permitting, feedstock/offtake. Pilot token $SAF to track production data; Louisiana flagship first.
7 April 2026
Fluor selected for FEED on America First Refining’s new Brownsville refinery
First new U.S. refinery in 50+ years; will process >60M barrels/year of domestic shale crude into gasoline, diesel and jet fuel using proven low-emission tech; contract value booked Q1 2026.
7 April 2026
Merck launches tender offer for Terns Pharmaceuticals
Begins cash tender offer of $53.00/share; expires May 4, 2026; closing conditioned on >50% tender, HSR clearance and customary conditions; expected to close in Q2 2026
← Previous
Next →
